Yeah, I agree with you. There's not much out there
Post# of 148154
There is Regeneron's REGN-COV2 antibody cocktail, which I think is a phase 2/3 trial. Although, I'm not sure how far along they can possibly be, or if they've even performed an interim analysis. I honestly haven't followed them too much, so they could be further along than I think, but I seem to remember their trial starting maybe 1-2 months ago at most, which is doesn't feel very long.